Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 17 studies | 50% ± 16% | |
goblet cell | 8 studies | 47% ± 20% | |
luminal cell of prostate epithelium | 4 studies | 26% ± 12% | |
deuterosomal cell | 3 studies | 34% ± 10% | |
duct epithelial cell | 3 studies | 34% ± 9% | |
ciliated cell | 3 studies | 25% ± 11% |
Insufficient scRNA-seq data for expression of LRRC26 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 95% | 2824.87 | 232 / 245 | 98% | 116.22 | 494 / 502 |
stomach | 72% | 167.89 | 258 / 359 | 47% | 10.89 | 135 / 286 |
breast | 60% | 428.39 | 276 / 459 | 42% | 7.57 | 472 / 1118 |
intestine | 48% | 328.96 | 465 / 966 | 45% | 20.82 | 239 / 527 |
skin | 59% | 172.32 | 1064 / 1809 | 0% | 0.08 | 1 / 472 |
esophagus | 23% | 46.38 | 337 / 1445 | 22% | 3.59 | 41 / 183 |
brain | 21% | 26.83 | 550 / 2642 | 0% | 0 | 0 / 705 |
pancreas | 16% | 8.19 | 53 / 328 | 4% | 3.24 | 7 / 178 |
lung | 11% | 11.61 | 63 / 578 | 8% | 1.27 | 87 / 1155 |
bladder | 0% | 0 | 0 / 21 | 15% | 5.41 | 78 / 504 |
uterus | 8% | 10.70 | 13 / 170 | 7% | 1.22 | 31 / 459 |
peripheral blood | 12% | 14.71 | 112 / 929 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 11% | 1.18 | 47 / 430 |
liver | 0% | 0.16 | 1 / 226 | 2% | 0.12 | 8 / 406 |
adipose | 2% | 4.06 | 25 / 1204 | 0% | 0 | 0 / 0 |
thymus | 1% | 0.62 | 4 / 653 | 0% | 0.01 | 1 / 605 |
muscle | 1% | 1.98 | 5 / 803 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.15 | 1 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 4.67 | 1 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 0% | 0.47 | 5 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 0.12 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1903818 | Biological process | positive regulation of voltage-gated potassium channel activity |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0015459 | Molecular function | potassium channel regulator activity |
GO_0005249 | Molecular function | voltage-gated potassium channel activity |
GO_0099104 | Molecular function | potassium channel activator activity |
GO_0005515 | Molecular function | protein binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
Gene name | LRRC26 |
Protein name | Leucine-rich repeat-containing protein 26 (BK channel auxiliary gamma subunit LRRC26) (Cytokeratin-associated protein in cancer) |
Synonyms | CAPC |
Description | FUNCTION: Auxiliary protein of the large-conductance, voltage and calcium-activated potassium channel (BK alpha). Required for the conversion of BK alpha channels from a high-voltage to a low-voltage activated channel type in non-excitable cells. These are characterized by negative membrane voltages and constant low levels of calcium. . |
Accessions | Q2I0M4 ENST00000371542.3 [Q2I0M4-1] |